지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.11
- 수록면
- 492 - 499 (8page)
이용수
초록· 키워드
오류제보하기
Backgrounds/Aims: Re-resection of incidental gallbladder carcinoma (IGBC) is possible in a select group of patients. However, the optimal timing for re-intervention lacks consensus.
Methods: A retrospective analysis was performed for a prospective database of 91 patients with IGBC managed from 2009 to 2018. Patients were divided into three groups based on the duration between the index cholecystectomy and re-operation or final staging: Early (E), < 4 weeks; Intermediate (I), > 4 weeks and < 12 weeks; and Late (L), > 12 weeks. Demographic data, tumor characteristics, and operative details of patients were analyzed to determine factors affecting the re-resectability of IGBC.
Results: Twenty-two patients in ‘E’, 48 in ‘I’, and 21 in ‘L’ groups were evenly matched. Nearly two thirds were asymptomatic. Curative resection was possible in 48 (52.7%) patients. Metastasis was detected during staging laparoscopy (SL)/laparotomy in 26 (28.6%) patients. The yield of SL was more in the ‘L’ group (30.8%) than in the ‘I’ (11.1%) or ‘E’ (nil) group, avoiding unnecessary laparotomy in 13.6%. Only 28.5% of patients in the ‘L’ group could undergo curative resection (R0/R1 resection), significantly less than that in the ‘E’ (50.0%) or ‘I’ group (64.6%) (both p < 0.001). On multivariate analysis, presentation in intermediate period and tumor differentiation increased the chance of curative resection (p < 0.05).
Conclusions: Asymptomatic patients in the ‘I’ group with well differentiated IGBC have the best chance of obtaining a curative resection.
Methods: A retrospective analysis was performed for a prospective database of 91 patients with IGBC managed from 2009 to 2018. Patients were divided into three groups based on the duration between the index cholecystectomy and re-operation or final staging: Early (E), < 4 weeks; Intermediate (I), > 4 weeks and < 12 weeks; and Late (L), > 12 weeks. Demographic data, tumor characteristics, and operative details of patients were analyzed to determine factors affecting the re-resectability of IGBC.
Results: Twenty-two patients in ‘E’, 48 in ‘I’, and 21 in ‘L’ groups were evenly matched. Nearly two thirds were asymptomatic. Curative resection was possible in 48 (52.7%) patients. Metastasis was detected during staging laparoscopy (SL)/laparotomy in 26 (28.6%) patients. The yield of SL was more in the ‘L’ group (30.8%) than in the ‘I’ (11.1%) or ‘E’ (nil) group, avoiding unnecessary laparotomy in 13.6%. Only 28.5% of patients in the ‘L’ group could undergo curative resection (R0/R1 resection), significantly less than that in the ‘E’ (50.0%) or ‘I’ group (64.6%) (both p < 0.001). On multivariate analysis, presentation in intermediate period and tumor differentiation increased the chance of curative resection (p < 0.05).
Conclusions: Asymptomatic patients in the ‘I’ group with well differentiated IGBC have the best chance of obtaining a curative resection.
목차
INTRODUCTION
PATIENTS AND METHODS
RESULT
DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
조기 위암의 내시경 치료 후 불완전 절제 시의 대책
대한의사협회지
2022 .05
-
Factors Affecting Endoscopic Curative Resection of Gastric Cancer in the Population-based Screening Era
Clinical Endoscopy
2018 .01
-
Prognosis after resection for lung metastasis after curative resection for colorectal cancer
대한외과학회 학술대회 초록집
2016 .05
-
Curative resection of bladder cancer pancreas head metastasis
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
The Benefits of Resection for Gastric Carcinoma Patients with Non-curative Factors
전남의대학술지
2018 .01
-
Curative Resection for Early Colorectal Cancer and Synchronous Metastasis: 2 cases
대한외과학회 학술대회 초록집
2019 .10
-
Non-Curative Resection: Should Clinicians Consider Providing Additional Surgery for All Patients?
Clinical Endoscopy
2020 .01
-
Retraction: Recurrence patterns and risk factors after curative resection in stage II gallbladder carcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2023 .11
-
Resection first
대한임상종양학회 학술대회지
2019 .02
-
Use of Statin Associated with Longer Survival in Patients with Pancreatic Cancer Undergoing Curative Resection
대한외과학회 학술대회 초록집
2023 .05
-
Is Radical Surgery Necessary for All Patients Diagnosed as Having Non-Curative Endoscopic Submucosal Dissection?
Clinical Endoscopy
2019 .01
-
Impact of the prognostic nutritional index on the recurrence of hepatocellular carcinoma patients after curative resection
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Non-curative endoscopic resection for superficial esophageal cancer
Clinical Endoscopy
2018 .01
-
Use of angiotensin inhibitor associated with longer survival in patients with pancreatic cancer undergoing curative resection
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Use of Angiotensin Inhibitor associated with Longer Survival in Patients with Pancreatic Cancer Undergoing Curative Resection
대한외과학회 학술대회 초록집
2022 .05
-
Sarcopenia with systemic inflammation can predict survival in patients with hepatocellular carcinoma undergoing curative resection
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
The Effect of Curative Resection on Fecal Microbiota in Patients with Colorectal Cancer: A Prospective Pilot Study
대한외과학회 학술대회 초록집
2018 .11
-
The risk factors of early recurrence and liver metastasis after curative resection for Ampullary cancer
대한외과학회 학술대회 초록집
2019 .10
-
30-day and In-hospital Mortality after Curative Resection of Gastric Cancer and Its Clinicopathologic Characteristics : Experience at a High Volume Center over 1,700 Cases a Year
대한임상종양학회 학술대회지
2015 .02
-
A Recent Argument for the Use of Endoscopic Submucosal Dissection for Early Gastric Cancers
Gut and Liver
2020 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0